- Home
- ORIS vs CRIS Comparison
ORIS vs CRIS Comparison
Compare ORIS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIS
- CRIS
- Stock Information
- Founded
- ORIS 2014
- CRIS 2000
- Country
- ORIS China
- CRIS United States
- Employees
- ORIS N/A
- CRIS N/A
- Industry
- ORIS Farming/Seeds/Milling
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ORIS Consumer Staples
- CRIS Health Care
- Exchange
- ORIS Nasdaq
- CRIS Nasdaq
- Market Cap
- ORIS 19.5M
- CRIS 21.3M
- IPO Year
- ORIS 2024
- CRIS 2000
- Fundamental
- Price
- ORIS $0.55
- CRIS $2.19
- Analyst Decision
- ORIS
- CRIS Strong Buy
- Analyst Count
- ORIS 0
- CRIS 2
- Target Price
- ORIS N/A
- CRIS $16.50
- AVG Volume (30 Days)
- ORIS 148.3K
- CRIS 76.0K
- Earning Date
- ORIS 02-21-2025
- CRIS 07-31-2025
- Dividend Yield
- ORIS N/A
- CRIS N/A
- EPS Growth
- ORIS N/A
- CRIS N/A
- EPS
- ORIS 0.17
- CRIS N/A
- Revenue
- ORIS $15,014,000.00
- CRIS $11,202,000.00
- Revenue This Year
- ORIS N/A
- CRIS N/A
- Revenue Next Year
- ORIS N/A
- CRIS $10.67
- P/E Ratio
- ORIS $3.26
- CRIS N/A
- Revenue Growth
- ORIS N/A
- CRIS 14.17
- 52 Week Low
- ORIS $0.51
- CRIS $1.02
- 52 Week High
- ORIS $56.01
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- ORIS N/A
- CRIS 50.37
- Support Level
- ORIS N/A
- CRIS $2.11
- Resistance Level
- ORIS N/A
- CRIS $2.26
- Average True Range (ATR)
- ORIS 0.00
- CRIS 0.20
- MACD
- ORIS 0.00
- CRIS -0.04
- Stochastic Oscillator
- ORIS 0.00
- CRIS 16.85
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.